Related references
Note: Only part of the references are listed.A Modular Lentiviral and Retroviral Construction System to Rapidly Generate Vectors for Gene Expression and Gene Knockdown In Vitro and In Vivo
Benjamin Geiling et al.
PLOS ONE (2013)
MEK1/2 Inhibition Elicits Regression of Autochthonous Lung Tumors Induced by KRASG12D or BRAFV600E
Christy L. Trejo et al.
CANCER RESEARCH (2012)
The RASSF3 Candidate Tumor Suppressor Induces Apoptosis and G1-S Cell-Cycle Arrest via p53
Takumi Kudo et al.
CANCER RESEARCH (2012)
SnapShot: Lung Cancer Models
Anna F. Farago et al.
CELL (2012)
Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
Leena Gandhi et al.
CLINICAL CANCER RESEARCH (2012)
The intermediate-activity L597VBRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway
Catherine Andreadi et al.
GENES & DEVELOPMENT (2012)
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
Kathryn M. Kinross et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A mouse model to identify cooperating signaling pathways in cancer
Monica Musteanu et al.
NATURE METHODS (2012)
The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis
Jun Wang et al.
CARCINOGENESIS (2011)
N-terminal RASSF family (RASSF7-RASSF10) A mini review
Nicholas Underhill-Day et al.
EPIGENETICS (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Genotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalities
Elizabeth M. Gaughan et al.
Therapeutic Advances in Medical Oncology (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity
Hoogeun Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Allosteric modulation of Ras positions Q61 for a direct role in catalysis
Greg Buhrman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The EML4-ALK Fusion Gene Is Involved in Various Histologic Types of Lung Cancers From Nonsmokers With Wild-type EGFR and KRAS
Daisy Wing-Sze Wong et al.
CANCER (2009)
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Nathalie Dhomen et al.
CANCER CELL (2009)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
Robert H. Kutner et al.
NATURE PROTOCOLS (2009)
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
Michel DuPage et al.
NATURE PROTOCOLS (2009)
RASSF2 associates with and stabilizes the proapoptotic kinase MST2
W. N. Cooper et al.
ONCOGENE (2009)
Use of the viral 2A peptide for bicistronic expression in transgenic mice
Georgios Trichas et al.
BMC BIOLOGY (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
The RASSF1A tumor suppressor
Howard Donninger et al.
JOURNAL OF CELL SCIENCE (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models
Hongbin Ji et al.
CANCER RESEARCH (2007)
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Christopher J. Sarkisian et al.
NATURE CELL BIOLOGY (2007)
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors
David Dankort et al.
GENES & DEVELOPMENT (2007)
Controlled expression of transgenes introduced by in vivo electroporation
Takahiko Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The role of RASSF1A methylation in cancer
Luke B. Hesson et al.
DISEASE MARKERS (2007)
The Drosophila RASSF homolog antagonizes the hippo pathway
Cedric Polesello et al.
CURRENT BIOLOGY (2006)
E unum pluribus:: multiple proteins from a self-processing polyprotein
P de Felipe et al.
TRENDS IN BIOTECHNOLOGY (2006)
Patterns of surgical care of lung cancer patients
AG Little et al.
ANNALS OF THORACIC SURGERY (2005)
The differential effects of mutant p53 alleles on advanced murine lung cancer
EL Jackson et al.
CANCER RESEARCH (2005)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis
L van der Weyden et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1
E O'Neill et al.
SCIENCE (2004)
RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family
K Eckfeld et al.
CANCER RESEARCH (2004)
CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer
M Irimia et al.
ONCOGENE (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate
P Rodriguez-Viciana et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mechanisms of cell-cycle arrest in Spitz Nevi with constitutive activation of the MAP-kinase pathway
JL Maldonado et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts
S Wu et al.
CELL (2003)
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
C Guerra et al.
CANCER CELL (2003)
Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo
LG Johnson et al.
HUMAN GENE THERAPY (2003)
Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression
G Lizée et al.
HUMAN GENE THERAPY (2003)
Genome-wide detection of LOH in prostate cancer using human SNP microarray technology
CI Dumur et al.
GENOMICS (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
GH Fisher et al.
GENES & DEVELOPMENT (2001)
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase γ
ME Pacold et al.
CELL (2000)
Ras1 promotes cellular growth in the Drosophila wing
DA Prober et al.
CELL (2000)
Share Paper
